Mark Hobraczk
@mhobraczk.bsky.social
130 followers
310 following
140 posts
Ai Arthritis Director of Public Policy based in Tampa Bay. Soccer dad and patient living with ankylosing spondylitis. University of Denver, JD. George Washington, MPA. Rutgers, BA. Opinions my own.
Posts
Media
Videos
Starter Packs
Reposted by Mark Hobraczk
Reposted by Mark Hobraczk
Reposted by Mark Hobraczk
Reposted by Mark Hobraczk
Reposted by Mark Hobraczk
FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary care setting.
https://www.medpagetoday.com/neurology/alzheimersdisease/117920
https://www.medpagetoday.com/neurology/alzheimersdisease/117920
Alzheimer's Blood Test Cleared for Primary Care Use
Elecsys pTau181 test can help rule out Alzheimer's-related amyloid pathology
www.medpagetoday.com
Reposted by Mark Hobraczk